Fly News Breaks for March 4, 2020
Mar 4, 2020 | 16:25 EDT
Citi analyst Joanne Wuensch initiated coverage of Abbott Laboratories with a Buy rating and $96 price target. The company is consistently delivering "top-tier" revenue growth and operating financial leverage, while generating significant cash flow, Wuensch tells investors in a research note. She also views Abbott's pipeline as "robust."
News For ABT From the Last 2 Days
There are no results for your query ABT